Company / Operating Cash Flow per Share
ENANTA PHARMACEUTICALS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.87
FY2025
5-year range
-$4.87 / $3.56
FY2021-FY2025
Trend
-20.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has declined for 4 consecutive years, from $3.56 in FY2021 to $-4.87 in FY2025.
Based on SEC 10-K filings.
-4.87 in FY2025.
Declined from $-3.37 to $-4.87 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENANTA PHARMACEUTICALS INC's operating cash flow per share has declined for 4 consecutive years.
- In FY2025, operating cash flow per share decreased 20.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.87 | -20.9% |
| FY2024 | -$4.03 | -19.6% |
| FY2023 | -$3.37 | -1061.3% |
| FY2022 | $0.35 | -90.2% |
| FY2021 | $3.56 | +139.9% |
| FY2020 | $1.48 | -45.4% |
| FY2019 | $2.71 | +45.0% |
| FY2018 | $1.87 | -53.5% |
| FY2017 | $4.03 | +273.6% |
| FY2016 | $1.08 | +88.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026